Xencor (XNCR) Liabilities and Shareholders Equity (2013 - 2026)

Xencor (XNCR) reported Liabilities and Shareholders Equity of $736.8 million for Q1 2026, down 18.55% year-over-year from $904.7 million in Q1 2025, and down 15.84% quarter-over-quarter from $875.5 million in Q4 2025.

Xencor (XNCR) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Liabilities and Shareholders Equity data on file, last reported at $736.8 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $736.8 million, down 18.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 billion (down 9.1% YoY), and the FY2025 annual result was $875.5 million, down 8.03% from the prior year.
  • Liabilities and Shareholders Equity fell to $736.8 million in Q1 2026 per XNCR's latest filing, from $875.5 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $999.9 million in Q3 2024 and troughed at $736.8 million in Q1 2026.
  • A 5-year average of $863.0 million and a median of $857.9 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity gained 28.45% in 2024, then slipped 18.55% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $846.3 million in 2022, then climbed by 14.05% to $965.1 million in 2023, then declined by 1.37% to $951.9 million in 2024, then decreased by 8.03% to $875.5 million in 2025, then slipped by 15.84% to $736.8 million in 2026.
  • Business Quant data shows XNCR's Liabilities and Shareholders Equity at $736.8 million in Q1 2026, $875.5 million in Q4 2025, and $868.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Xencor 953.38 Mn 878.64 Mn - 736.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 736.85 Mn
Dec 31, 2025 875.50 Mn
Sep 30, 2025 868.81 Mn
Jun 30, 2025 879.42 Mn
Mar 31, 2025 904.69 Mn
Dec 31, 2024 951.95 Mn
Sep 30, 2024 999.90 Mn
Jun 30, 2024 840.62 Mn
Mar 31, 2024 896.85 Mn
Dec 31, 2023 965.14 Mn
Sep 30, 2023 778.43 Mn
Jun 30, 2023 778.12 Mn
Mar 31, 2023 803.41 Mn
Dec 31, 2022 846.27 Mn
Sep 30, 2022 835.27 Mn
Jun 30, 2022 851.33 Mn
Mar 31, 2022 857.92 Mn
Dec 31, 2021 838.21 Mn
Sep 30, 2021 697.26 Mn
Jun 30, 2021 695.60 Mn